JVM Co

JVM Co Equity Turnover

The Equity Turnover of JVM Co (054950.KQ) as of Nov 3, 2026 is 0.74. In the previous year, Equity Turnover was 0.79 — a change of -6.08% (lower).

Equity Turnover

0.74

YoY

-6.08%

Last updated:

Equity Turnover of JVM Co is 2025 0.74 . Equity Turnover of JVM Co was 2024 0.79 . It decreases by -6.08% lower compared to the previous year.

The JVM Co Equity Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Turnover
Date
Equity Turnover
Jan 1, 2018
0.84 KRW
Jan 1, 2019
0.89 KRW
Jan 1, 2020
0.84 KRW
Jan 1, 2021
0.81 KRW
Jan 1, 2022
0.90 KRW
Jan 1, 2023
0.88 KRW
Jan 1, 2024
0.79 KRW
Jan 1, 2025
0.74 KRW
The JVM Co Equity Turnover history
YEAREquity TurnoverYoY
0.74-6.08%
0.79-9.96%
0.88-2.53%
0.90+11.24%
0.81-3.93%
0.84-5.70%
0.89+5.90%
0.84-4.00%
0.88+0.16%
0.88+3.77%
0.84-5.52%
0.89—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

JVM Co Stock analysis

What does JVM Co do? JVM Co., Ltd. manufactures pharmacy automation systems under the brand JVM, targeting domestic and overseas markets. The company's primary products include automatic tablet dispensing and packaging systems (ATDPSs), automatic tablet classification and packing machines available in slide, box, and drum types, total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), and automatic medication sorting and control systems (AccuPharm). These products are sold to customers in the pharmaceutical and healthcare sectors seeking efficient automation solutions for medication handling and safety. The firm generates revenue through the sale of its branded automation systems, with a focus on domestic distribution and international markets. JVM's product portfolio addresses key operational needs in pharmacy settings, including dispensing, classification, inspection, and sorting of medications, ensuring compliance with safety standards while improving workflow efficiency. The company's offerings are designed to meet the demands of healthcare providers and pharmaceutical manufacturers requiring advanced automation technologies. JVM's business model centers on providing comprehensive automation solutions for pharmacy operations, leveraging its established brand JVM to differentiate its products in the market. By offering a wide range of specialized systems, the company caters to both domestic and international clients seeking reliable, high-quality automation equipment for medication management and safety protocols. JVM Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JVM Co stock

Equity Turnover of JVM Co is 0.74 in 2025.

Equity Turnover of JVM Co changed from 0.79 to 0.74, representing a -6.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Turnover JVM Co since 2006 – with annual values, charts, and detailed analysis.

Equity turnover measures how efficiently a company uses shareholders' equity to generate revenue. It is a component of the DuPont analysis framework.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Turnover's JVM Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Equity Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Equity Turnover.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — JVM Co

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — JVM Co